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Extracellular matrix (ECM) is an intricate mesh of collagenous and non-colla-
genous proteins, whose presence and amount vary according to type of tissue. ECM 
drew the attention of regenerative medicine scientists as natural scaffold suitable 
for stem cell delivery into damaged tissues. Although a multitude of protocols and 
combinations of chemical agents and physical methods have been tested and proved 
effective in the decellularization of human heart, none of the ones tried in our set-
ting fulfilled the goal of obtaining a structurally preserved cardiac decellularized 
ECM (d-ECM). While testing already described procedures, we made several adjust-
ments that led to the development of a novel, simpler and robust protocol to decel-
lularize adult human heart. Specifically, we decellularized cardiac samples of the free 
wall of both ventricles of adult human hearts scaled down to fit into embedding cas-
settes used to avoid stirring stress and preserve structure. To shorten the procedure, 
a combination of SDS, Triton X-100 and antibiotics was used in simple and fast two-
step protocol. After decellularization, d-ECM was fixed and processed for histological 
study or snap-frozen for molecular biology analysis or cytocompatibility test in vitro. 
Histochemistry and immunoistochemistry confirmed the absence of nuclei and the 
preservation of architecture and composition of d-ECM. Further, while DNA content 
in d-ECM was well below accepted standards, sGAG, elastin and growth factors were 
retained and d-ECM scaffolds supported cardiac primitive cell engraftment and sur-
vival in vitro. Hence, according to our evidence, our protocol is simple, fast, effective 
and is worth improving for clinical translation.
